Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-24 @ 9:24 PM
NCT ID:
NCT02639832
Eligibility Criteria:
Inclusion Criteria:
* Signed Informed Consent Form.
* Female.
* Over 18 years of age.
* Previously Treated Non-metastatic Triple Negative Breast Cancer or Women with Previously Treated Non-metastatic Breast Cancer With a confirmed BRCA Mutation who have completed therapy within three years of enrollment in this study.
* Subject may be invited to annual review of the Subject Information and Donation Schedule by email or mail follow up for five years after sampling.
* Subject provides written authorization for use and disclosure of protected health information (PHI).
Exclusion Criteria:
* Any conditions inappropriate for blood drawing.
* Known active viral or bacterial infection at time of blood draw.
* Known HIV, Hepatitis B, or Hepatitis C infection.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02639832
Study Brief:
Protocol Section:
NCT02639832